Drug Delivery System
Online ISSN : 1881-2732
Print ISSN : 0913-5006
ISSN-L : 0913-5006
[Feature articles]“Clinical application of DDS in cancer chemotherapy” Editor:Tetsuya Hamaguchi
The history of Granulocyte-colony stimulating factor
Momoko TakahashiChihiro KondohToshimi Takano
Author information
JOURNAL FREE ACCESS

2017 Volume 32 Issue 2 Pages 134-142

Details
Abstract

Granulocyte-colony stimulating factor is a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cells and release them into the bloodstream. Pegylated G-CSF(pegfilgrastim), in which the addition of polyethylene glycol increases the half-life of the agent, decreases the incidence of febrile neutropenia during chemotherapy. The use of G-CSF support is also important to increase dose intensity or dose density of chemotherapy. Pegylated materials are expected to play an important role in cancer treatment.

Content from these authors
© 2017 The Japan Society of Drug Delivery System
Previous article Next article
feedback
Top